Session Information
AABB Annual Meeting and CTTXPO 2010
Click here to go to the previous page
Ask the Biovigilance Experts
Track
:
TC- Technical/Clinical
Program Code:
9331-TC
Date:
Monday, October 11, 2010
Time:
2:00 PM to 3:30 PM
EST
Location:
327/328
DIRECTOR
:
Barbee Whitaker, PhD, Director, Research and AABB Center for Patient Safety, AABB
MODERATOR
:
D. Michael Strong, PhD, MT(ASCP), Adjunct Professor, Department of Orthopaedics and Sports Medicine, University of Washington, School of Medicine
SPEAKER
(S):
Barbee Whitaker, PhD, Director, Research and AABB Center for Patient Safety, AABB
Linda Hahn, MT(ASCP)SBB, MPM, Vice President ITxM Clinical Services, Institute For Transfusion Medicine
Kevin Land, MD, VP of Clinical Services, Blood Systems, Inc.
Alexis Harvey, MSPH, Health Scientist, Centers for Disease Control and Prevention
Dr. Beth Shaz, MD, Chief Medical Officer, New York Blood Center
TENTATIVE DIRECTOR
:
Barbee Whitaker, PhD, Director, Research and AABB Center for Patient Safety, AABB
Description
This event provides an opportunity for a panel representing various public and private perspectives to discuss the current landscape in biovigilance. Included will be representatives from the CDC's National Healthcare Safety Network - Hemovigilance Module, AABB's Biovigilance Working Group who developed the definitions and content of the Hemovigilance Module, AABB's Donor Hemovigilance Working Group, and AABB's Patient and Donor Safety Center. Questions for the discussion can be submitted before the scheduled session via the AABB Web site beginning in September, as well as during the session.
LEARNER OUTCOMES:
- Describe services provided by AABB's Patient and Donor Safety Center and the confidentiality provisions it affords.
- Describe the rationale behind the development of the hemovigilance forms and definitions used in the Hemovigilance Module.
- Interprete and describe the CDC's hemovigilance protocol and how to use the Hemovigilance Module of the National Healthcare Safety Network (NHSN).
- Review other biovigilance systems, proposed or existing.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
This session is a part of:
Online Access
(Code: 9331-TC)
Attendee/Member:$25 USD
Attendee:$40 USD
Member:$40 USD
Non-Attendee/Non-Member $50 USD - Your Price
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |